AI-designed drug appears to turn back the body's biological clock in early trial

A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42…

A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet. The article AI-designed drug appears to turn back the body's biological clock in early trial appeared first on The Decoder.

Source: The Decoder — Published September 7, 2026 at 16:34 UTC — Category: Models